Female Fertility Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Female Fertility Drugs Market By drug type, (Gonadotrophins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators, Follicle Stimulating Hormones, Dopamine Agonists, Metformin Hydrochloride, Others)  by distribution mode, (Prescription Fertility Drugs, Over-The-Counter Fertility drugs) by route of administration, (Oral,Parenteral) by distribution channel, (Hospital pharmacies, Retail pharmacies, Online pharmacies) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global female fertility drugs market size valued $3.28 billion in 2020 expected to reach $6.4 billion in 2027, at a CAGR of 6.3% during forecast period 2021-2027. Female fertility drugs are the agents used to improve the reproductive health in the women and act stimulating the follicle development of ovary. Women fertility drugs are extremely effective and first treatment option to overcome the infertility. Fertility drugs act by direct stimulation of ovaries or balancing the hormone levels. Infertility in women is occur due to hypothalamic dysfunction, excessive prolactin, pelvic inflammatory diseases, premature ovarian insufficiency, and polycystic ovary syndrome among others. The major symptom associated with the infertility is absence or irregular menstrual cycle. female fertility drugs market is growing at a significant CAGR with several local and international players operating in the infertility treatment. The prevalence of infertility is increasing due to change in lifestyle such as smoking and alcohol consumption. According to World Health Organization, approximately 60-80 Mn couples are suffering from infertility around the world. Moreover, acquisitions & mergers, collaborations, product approvals and product launchings are the strategies followed by the companies for increasing their market revenue share in female fertility drugs market. For instance, in March 2014, Ferring Pharmaceuticals received FDA approval for the combination of Menopur and Bravelle injection used in the treatment of infertility.

Female Fertility Drugs Market

MARKET SUMMARY
-
6.3% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 6.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Female Fertility Drugs Market

  • The report on global female fertility drugs market gives historical, current and future market sizes (US$ Bn) based on drug type, distribution mode, route of administration, distribution channel and geographical regions.
  • female fertility drugs market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Sanofi S.A.
  • Merck KGaA
  • Novartis AG
  • Ferring B.V.
  • Eli Lilly and Co.
  • Serono, Inc.
  • Pfizer, Inc.

 

Female Fertility Drugs Market

Drivers And Restraints

Increase in the female population, rise in prevalence of infertility condition due to change in lifestyle, government initiation for the infertility management, rise in disposable income are anticipated to fuel the women fertility drugs market over the forecast period. Moreover, increase in R&D activities for the development of new drugs to overcome the infertility, rise in the prevalence of obesity, and increase in the maternal age are expected to boost the women fertility drugs market. However, stringent regulatory policies for drug approvals, lack of awareness about women fertility drugs in underdeveloped countries, and alternative infertility treatments such as in vitro fertilization are expected to restrain the growth of women fertility drugs market over the forecast period.


North-America got significant share

Female Fertility Drugs Market

Geographically, female fertility drugs market is segmented into the North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America driven by increase in the prevalence of female infertility rate due to obesity and lifestyle changes, increase in the R&D activities for the innovation of newer drugs, and rise in awareness about the fertility drugs among the key stakeholders in the region. Europe exhibiting significant growth rate owing to accessibility of the products, increase in the infertility rate in female due to hormonal imbalance, and lifestyle changes are the factors boost in the region. Moreover, Asia Pacific garnered significant share due to rise in female adult population, rise in female genital mutilation, and adoption of newer drugs in the region are the factors expected to upsurge the revenue of female fertility drugs market in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In May 2017. Merck KGaA received European Commission Grants approval for Pergoveris prefilled injection used in the treatment of follicle stimulating hormone (FSH) and Leutinizing hormone (LH) deficiency

Key

Key Features of the Report

Female Fertility Drugs Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Female Fertility Drugs Market Introduction
    • Global Female Fertility Drugs Market – Taxonomy
    • Global Female Fertility Drugs Market –Definitions
      • Drug Type
      • Distribution Mode
      • Route of Administration
      • Distribution Channel
  1. Global Female Fertility Drugs Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Female Fertility Drugs Market Dynamic Factors – Impact Analysis
    • Global Female Fertility Drugs Market – Competition Landscape
    • Epidemiology
  2. Global Female Fertility Drugs Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Female Fertility Drugs Market, By Drug Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Gonadotrophins
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Aromatase Inhibitors
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Selective Estrogen Receptor Modulators
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Follicle Stimulating Hormones
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Dopamine Agonists
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Metformin Hydrochloride
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Distribution Mode,2013 – 2017 and Forecast, 2018 – 2024
    • Prescription Fertility Drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Over-The-Counter Fertility drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Route of Administration,2013 – 2017 and Forecast, 2018 – 2024
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Female Fertility Drugs Market – Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Region, 2018 – 2024
  2. North America Female Fertility Drugs MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Female Fertility Drugs Market – Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2018 – 2024
    • North America Female Fertility Drugs Market Dynamics – Trends
  3. Europe Female Fertility Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Female Fertility Drugs Market – Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2018 – 2024
    • Europe Female Fertility Drugs Market Dynamics – Trends
  4. Asia-Pacific Female Fertility Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Female Fertility Drugs Market – Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2018 – 2024
    • Asia-Pacific Female Fertility Drugs Market Dynamics – Trends
  5. Latin America Female Fertility Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Female Fertility Drugs Market – Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2018 – 2024
    • Latin America Female Fertility Drugs Market Dynamics – Trends
  6. Middle East and Africa Female Fertility Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Female Fertility Drugs Market – Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2018 – 2024
    • MEA Female Fertility Drugs Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Sanofi S.A. (France)
      • Merck KGaA (Germany)
      • Novartis AG (Switzerland)
      • Ferring B.V. (Switzerland)
      • Berlex Laboratories Inc. (U.S.)
      • Eli Lilly and Co. (U.S.)
      • Serono, Inc. (U.S.)
      • Novogyne Pharmaceuticals (U.S.)
      • Pfizer, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Sanofi S.A. (France)
  • Merck KGaA (Germany)
  • Novartis AG (Switzerland)
  • Ferring B.V. (Switzerland)
  • Berlex Laboratories Inc. (U.S.)
  • Eli Lilly and Co. (U.S.)
  • Serono, Inc. (U.S.)
  • Novogyne Pharmaceuticals (U.S.)
  • Pfizer, Inc. (U.S.)

Description

The global female fertility drugs market size valued $3.28 billion in 2020 expected to reach $6.4 billion in 2027, at a CAGR of 6.3% during forecast period 2021-2027. Female fertility drugs are the agents used to improve the reproductive health in the women and act stimulating the follicle development of ovary. Women fertility drugs are extremely effective and first treatment option to overcome the infertility. Fertility drugs act by direct stimulation of ovaries or balancing the hormone levels. Infertility in women is occur due to hypothalamic dysfunction, excessive prolactin, pelvic inflammatory diseases, premature ovarian insufficiency, and polycystic ovary syndrome among others. The major symptom associated with the infertility is absence or irregular menstrual cycle. female fertility drugs market is growing at a significant CAGR with several local and international players operating in the infertility treatment. The prevalence of infertility is increasing due to change in lifestyle such as smoking and alcohol consumption. According to World Health Organization, approximately 60-80 Mn couples are suffering from infertility around the world. Moreover, acquisitions & mergers, collaborations, product approvals and product launchings are the strategies followed by the companies for increasing their market revenue share in female fertility drugs market. For instance, in March 2014, Ferring Pharmaceuticals received FDA approval for the combination of Menopur and Bravelle injection used in the treatment of infertility.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX